本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ultragenyx Pharmaceutical Inc

14.92
-0.3800-2.48%
盘后:15.040.1200+0.80%19:55 EDT
成交量:530.63万
成交额:7,912.21万
市值:14.67亿
市盈率:-2.56
高:15.39
开:15.27
低:14.69
收:15.30
52周最高:39.89
52周最低:12.73
股本:9,831.72万
流通股本:8,071.56万
量比:1.38
换手率:6.57%
股息:- -
股息率:- -
每股收益(TTM):-5.8279
每股收益(LYR):-5.8316
净资产收益率:-608.47%
总资产收益率:-24.22%
市净率:-5.04
市盈率(LYR):-2.56

数据加载中...

2019/09/04

重要事件披露

Current report, items 7.01, 8.01, and 9.01
2019/08/14

重要事件披露

Current report, items 7.01, 8.01, and 9.01
2019/08/02

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/08/01

重要事件披露

Current report, items 2.02 and 9.01
2019/08/01

重要事件披露

Current report, items 8.01 and 9.01
2019/07/17

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/09

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/26

超过5%披露

General statement of acquisition of beneficial ownership
2019/06/25

持股变动声明

Initial statement of beneficial ownership of securities
2019/06/24

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/21

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/21

持股变动声明

Initial statement of beneficial ownership of securities
2019/06/20

重要事件披露

Current report, items 8.01 and 9.01
2019/06/17

重要事件披露

Current report, item 5.07
2019/06/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/13

持股变动声明

Statement of changes in beneficial ownership of securities